Read the announcement: LAIV Influenza Vaccine Approved in China Melbourne
Highlights: • LAIV flu vaccine royalty receipt • Progress in Opal’s bid to secure lease to GSK Boronia manufacturing plant • EOFY 2021 share price information Read the full annoucement
Announcement of Board Changes
